Bank Of America Corp Synthetic Biologics, Inc. Transaction History

Bank Of America Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.3 - $4.3 $572 - $1,070	-249 Reduced 81.11%	58 $0
Q4 2021 Feb 08, 2022	SELL	$2.7 - $4.5 $1,150 - $1,917	-426 Reduced 58.12%	307 $0
Q3 2021 Nov 15, 2021	BUY	$4.3 - $5.8 $2,631 - $3,549	612 Added 505.79%	733 $0
Q2 2021 Sep 13, 2021	BUY	$4.6 - $7.2 $556 - $871	121 New	121 $0

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.